(Q51550632)

6 April 2018

title

Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes. (English)

1 reference

6 April 2018

1 reference

2

Ranstam J

1 reference

6 April 2018

Hermann LS

1

1 reference

6 April 2018

Vaaler S

series ordinal

3

1 reference

6 April 2018

Melander A

series ordinal

4

1 reference

6 April 2018

publication date

1 July 1999

1 reference

6 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

6 April 2018

volume

1

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

227-232

1 reference

6 April 2018

Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

The insulin resistance syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Banting lecture 1990. Beta-cells in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Effect of Conventional and Intensified Insulin Therapy on Free-Insulin Profiles and Glycemic Control in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

21 January 2018

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00034.X

10.1046/J.1463-1326.1999.00034.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

release_54aweeca25efbfqmf6liselrce

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/54aweeca25efbfqmf6liselrce

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11228758

1 reference

6 April 2018